Results 231 to 240 of about 249,494 (353)

Prescription Drug Misuse in "Clubbers" and Disco Goers in Ibiza. [PDF]

open access: yesFront Psychiatry, 2020
di Giannantonio M   +17 more
europepmc   +1 more source

Potential for use of Al/machine learning for pharmacovigilance: Is there a role for regulators?

open access: yes
British Journal of Clinical Pharmacology, EarlyView.
Christina Gao   +3 more
wiley   +1 more source

Zuranolone: A case study in (regulatory) rush to judgement?

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove   +4 more
wiley   +1 more source

Patterns of Prescription Drug Misuse among Young Injection Drug Users [PDF]

open access: bronze, 2012
Stephen E. Lankenau   +5 more
openalex   +1 more source

Attention-Deficit Hyperactivity Disorder Stimulant Therapy and Prescription Drug Misuse During Transition to Young Adulthood. [PDF]

open access: yesPsychiatr Serv
McCabe SE   +6 more
europepmc   +1 more source

‘They just want the perfect kids on show’: The illegal exclusion of children with special educational needs and disabilities from primary schools

open access: yesBritish Educational Research Journal, EarlyView.
Abstract Guidance from the Department for Education stipulates that permanent exclusions should only be used as a last resort and where there is potential for harm to come to anyone in the school setting. Suspensions are positioned as a tool to communicate to a pupil that their behaviour is in breach of the school's behaviour policy.
Megan Whitehouse
wiley   +1 more source

Home - About - Disclaimer - Privacy